http://www.vpgmarketresearch.com/Molecular-Blood-Typing--Grouping-and-Infectious-Disease-NAT-Market--France--Germany--Italy--Japan--Spain--UK--US--Emerging-Technologies--Sales-Forecasts--Supplier-Shares--Competitive-Strategies.html">2014 Molecular Blood Typing, Grouping and Infectious Disease NAT MarketFrance, Germany, Italy, Japan, Spain, UK, US--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies
These thought-provoking reports are designed to provide the in vitro diagnostics industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs.
The studies offer expert analyses, strategic insights and granular data, such as supplier shares and sales forecasts for over 400 diagnostic tests by country and market segment.
The reports are available by region, country, section, market segment, individual test, and can be custom-tailored to specific information needs and budget.
The global diagnostic market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances will radically change the global diagn
Page: 1 2 3 4 Related medicine technology :1
|SOURCE Venture Planning Group|
Copyright©2014 PR Newswire.
All rights reserved
. QBC Diagnostics Awarded GSA Contract2
. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date3
. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan4
. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy5
. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics6
. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference7
. Breakthrough Prostate Cancer Diagnostics8
. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics9
. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets10
. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics11
. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19